30-05-2026 06:57 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  About Us   Services             Trading   Depository    
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Company News
Dr. Reddy's Laboratories Ltd.
Change Company   
BSE Code 500124
ISIN Demat INE089A01031
Book Value 375.79
NSE Code DRREDDY
Dividend Yield % 0.61
Market Cap 1087516.30
P/E 33.78
EPS 38.58
Face Value 1  
16-May-2026 Dr. Reddy's Laboratories launches generic Semaglu...
16-May-2026 Dr. Reddy’s Laboratories informs about press rel...
13-May-2026 Dr. Reddy's Laboratories reports 86% plunge in Q4...
29-Apr-2026 Dr. Reddy's Lab gets Health Canada’s nod for Gene...
29-Apr-2026 Dr. Reddy’s Laboratories informs about updates
24-Apr-2026 Clarification sought from Dr Reddys Laboratories...
24-Apr-2026 Dr. Reddy’s Laboratories informs about clarificat...
23-Apr-2026 Clarification sought from Dr Reddys Laboratories...
09-Apr-2026 Dr. Reddy’s Laboratories informs about compliance...
08-Apr-2026 Dr. Reddy's Laboratories to sell entire sharehold...
21-Mar-2026 Dr. Reddy’s Laboratories launches Semaglutide inj...
21-Mar-2026 Dr. Reddy’s Laboratories informs about media rel...
21-Mar-2026 Dr Reddys Laboratories informs about press release
06-Mar-2026 Dr. Reddy's Laboratories gets EIR for Andhra Prad...
05-Mar-2026 Dr. Reddy’s Laboratories informs about updates
Page 1 of 3
Prev || Next
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Few Important Links: NSE | BSE | NSDL | CDSL | SEBI | MCX | NCDEX | FMC | RBI | AMFI | My Company GST Number | SCORES | DP 15 | BSE PLUS
Contact Us | Careers | Downloads | Notice |Margin Obligation Circular |Creating Investor | Policies| Details of KMPS | Public information for Investors
Circular | BOI UPI ID & QR Code
SEBI Reg. No INZ000209538 Depository CDSL: IN-DP-15-2015 Research Reg. No.: INH000011219
© 2006 J G Shah Financial Consultants Pvt.Ltd. All rights reserved.
Designed || Developed & Content Powerd By Accord Fintech Pvt. Ltd.